| dc.contributor.author | Salama, Mohamed | |
| dc.contributor.author | Yuan, Ti-Fei | |
| dc.contributor.author | Machado, Sergio | |
| dc.contributor.author | Murillo Rodríguez, Eric | |
| dc.contributor.author | Vega Álvarez, José Antonio | |
| dc.contributor.author | Menéndez González, Manuel | |
| dc.contributor.author | Nardi, Antonio E. | |
| dc.contributor.author | Arias Carrión, Óscar | |
| dc.date.accessioned | 2013-11-27T11:28:44Z | |
| dc.date.available | 2013-11-27T11:28:44Z | |
| dc.date.issued | 2013 | |
| dc.identifier.citation | Cns & Neurological Disorders-Drug Targets, 12(5), p. 641-664 (2013) | |
| dc.identifier.issn | 1871-5273 | |
| dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/23574157 | |
| dc.identifier.uri | http://hdl.handle.net/10651/19678 | |
| dc.format.extent | p. 641-664 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Cns & Neurological Disorders-Drug Targets | en |
| dc.rights | ©, | |
| dc.title | Co-Enzyme Q10 to Treat Neurological Disorders: Basic Mechanisms, Clinical Outcomes, and Future Research Direction | en |
| dc.type | journal article | |
